Rayence Co

Rayence Co Operating Expenses

The Total Operating Expenses of Rayence Co (228850.KQ) as of Nov 7, 2026 is 26.47 B KRW. In the previous year, Total Operating Expenses was 37.25 B KRW — a change of -28.95% (lower).

Operating Expenses

26.47 BKRW

YoY

-28.95%

Last updated:

Total Operating Expenses of Rayence Co is 2025 26.47 B KRW. Total Operating Expenses of Rayence Co was 2024 37.25 B KRW. It decreases by -28.95% lower compared to the previous year.

The Rayence Co Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
18.74 B KRW
Jan 1, 2019
20.08 B KRW
Jan 1, 2020
22.90 B KRW
Jan 1, 2021
27.64 B KRW
Jan 1, 2022
33.39 B KRW
Jan 1, 2023
34.01 B KRW
Jan 1, 2024
37.25 B KRW
Jan 1, 2025
26.47 B KRW
The Rayence Co Operating Expenses history
YEAROperating ExpensesYoY
26.47 BKRW-28.95%
37.25 BKRW+9.51%
34.01 BKRW+1.86%
33.39 BKRW+20.80%
27.64 BKRW+20.71%
22.90 BKRW+14.04%
20.08 BKRW+7.14%
18.74 BKRW-31.32%
27.29 BKRW-2.63%
28.03 BKRW+101.45%
13.91 BKRW-28.05%
19.34 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rayence Co Stock analysis

What does Rayence Co do? Rayence Co., Ltd. generates revenue through the manufacturing and sale of x-ray detectors, including TFT and CMOS detectors under brand names such as 1012WCA, 17SCC/SGC, 1215CF, 1501CF, and 0712CF. The company also produces intra oral sensors branded as Ez1.0 and Ez1.5, along with mammography machines under the 1724CM and 2434CM series. These products are distributed to both domestic and international markets, serving healthcare providers and medical facilities that require diagnostic imaging equipment. The primary customers for Rayence's detectors and sensors are hospitals, clinics, and medical imaging centers seeking advanced x-ray technology. The firm's product portfolio targets the medical imaging segment, focusing on applications such as dental diagnostics with intra oral sensors and radiological imaging with mammography machines. Revenue streams are derived from direct sales of these branded products to healthcare institutions across multiple regions. Rayence's business model centers on selling specialized medical imaging equipment under its own brand names, with no mention of third-party partnerships or additional services. The company's revenue is directly tied to the purchase of its branded x-ray detectors, intra oral sensors, and mammography machines by healthcare providers who require high-quality diagnostic tools for patient care. Rayence Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rayence Co stock

Total Operating Expenses of Rayence Co is 26.47 B KRW in 2025.

Total Operating Expenses of Rayence Co changed from 37.25 B KRW to 26.47 B KRW, representing a -28.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Rayence Co since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Rayence Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Rayence Co

All Key Metrics — Rayence Co